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Abstract
Background
Accurate and efficient detection of sub-microscopic malaria infections is crucial for enabling
rapid treatment and interruption of transmission. Commercially available malaria LAMP kits
have excellent diagnostic performance, though throughput is limited by the need to prepare
samples individually. Here, we evaluate the clinical performance of a newly developed high
throughput (HTP) sample processing system for use in conjunction with the Eiken malaria
LAMP kit.
Methods
The HTP system utilised dried blood spots (DBS) and liquid whole blood (WB), with parallel
sample processing of 94 samples per run. The system was evaluated using 699 samples of
known infection status pre-determined by gold standard nested PCR.
Results
The sensitivity and specificity of WB-HTP-LAMP was 98.6% (95% CI, 95.7–100), and
99.7% (95% CI, 99.2–100); sensitivity of DBS-HTP-LAMP was 97.1% (95% CI, 93.1–100),
and specificity 100% against PCR. At parasite densities greater or equal to 2 parasites/μL,
WB and DBS HTP-LAMP showed 100% sensitivity and specificity against PCR. At densities
less than 2 p/μL, WB-HTP-LAMP sensitivity was 88.9% (95% CI, 77.1–100) and specificity
was 99.7% (95% CI, 99.2–100); sensitivity and specificity of DBS-HTP-LAMP was 77.8%
(95% CI, 54.3–99.5) and 100% respectively.
Conclusions
The HTP-LAMP system is a highly sensitive diagnostic test, with the potential to allow large
scale population screening in malaria elimination campaigns.
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Introduction
Successful elimination of malaria is dependent on accurate and efficient diagnoses to actively
treat and clear parasite infections, thereby interrupting transmission to new hosts. Microscopic
examination of thick and thin blood smears remains a commonly used method for diagnosis
of malarial infections [1], capable of detecting parasites in less than 60 minutes. Microscopy-
based diagnosis is completely dependent upon the skill of trained microscopists and imple-
mentation of regular external quality assessment (EQA) schemes. The development of anti-
gen-based rapid diagnostic tests (RDTs) allows for quick and accurate detection of infections
[2]. Such testing is relied upon in areas lacking trained microscopists and specialised diagnos-
tic equipment, and is increasingly being used for diagnostic testing over microscopy [3]. How-
ever, both techniques have limited sensitivity: the lowest detection limit is 5 to 50 parasites per
microLitre (p/μL) of blood for expert microscopy, and around 100 p/μL for RDTs-, and there-
fore inadequate for detection of infections below these levels, which frequently occur [1, 3–6].
Malaria elimination programs require case management and community surveillance of
asymptomatic infections which are sub-patent, i.e. where parasitaemia is below the threshold
of detection by microscopy and RDTs, as such infections have proven capable of sustaining
transmission of gametocytes to mosquitoes during blood meal feeds. Detecting such infections
is particularly important during mass screen and treatment (MSAT) programs driving elimi-
nation efforts in these areas [7]. Therefore, highly sensitive molecular techniques for the detec-
tion of low density parasitaemia, such as nucleic acid amplification tests (NAATs), capable of
detecting trace amounts of parasite DNA are needed.
Polymerase chain reaction (PCR) is one such test capable of amplifying low levels of para-
site DNA. It allows highly sensitive detection of parasite DNA below the threshold of detection
for microscopy and RDTs, making it the gold standard for detection of malarial parasitaemia
[8, 9]. However, most PCR assays require specialised infrastructure with costly equipment and
reagents, plus specialised training and results can take up to two days to generate from receipt
of the sample, making it inappropriate to guide treatment. Loop mediated isothermal amplifi-
cation (LAMP) is a molecular tool similar to PCR in that it amplifies parasite DNA with PCR
level accuracy, whilst providing several advantages over PCR particularly for detection of
infections in field settings [10, 11]. Amplification occurs in a single step under isothermal con-
ditions using the Bacillus stearothermophilus polymerase enzyme, which does not require a
high temperature denaturation step, or cyclical temperature changes, eliminating the require-
ment for expensive thermocyclers. Real-time detection can be performed using basic equip-
ment i.e. a turbidimeter or visually using a UV light, compared to gel electrophoresis or real-
time PCR machines required for PCR and qPCR respectively, and therefore suitable for labora-
tories lacking specialised infrastructure [12–14]. The method is also less time intensive with
simpler sample processing requirements, and results can be obtained in under an hour, mak-
ing it more suitable for field-based diagnostics. This has led to the development of two com-
mercially available, CE marked, field-stable LoopampTM kits (Eiken Chemical Co.) for the
detection of all Plasmodium spp. (Pan only kit) and P. falciparum specifically (Pan/Pf kit),
which have been trialled in reference laboratory settings in UK and Europe, and in field set-
tings in Uganda, Zanzibar and Colombia [10, 11, 15–19]. These amplification kits have been
coupled with bespoke rapid DNA extraction technology (PURE), capable of extracting DNA
without the need for pipetting or centrifugation. Alternatively, a simple boil and spin protocol
(BS-LAMP) allows rapid extraction and amplification of DNA by LAMP [20].
While LAMP assays are capable of detecting parasite DNA in under an hour, throughput is
restricted by time taken for sample processing and DNA extraction. The use of colorimetric
indicators for visual detection of high throughput LAMP-amplified parasite DNA has been
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described [21–23]. Britton et al. describe a technique which uses 96 well plates for performing
high throughput LAMP reactions using the dye hydroxynaphthol blue for a visual end point
readout. However, the separate DNA extraction step is time-consuming with completion of
the assay taking 4–6 hours. [21, 22]. Lucchi et al. describe a high throughput system utilising
malachite green dye for visual assessment of LAMP products [23]. This system is compatible
with the use of DNA extracted from whole blood as well as filter papers and showed a limit of
detection between 1–8 p/μL. However, both colorimetric high throughput assays have separate
sample preparation steps and utilise extemporaneously prepared LAMP reagents requiring
additional pipetting steps as well as cold storage facilities and is not field adaptable when com-
pared to stable kits with dried-down reagents.
The recently described Illumigene Malaria LAMP assays [24] use pre-dispensed, lyophilized
reagents stable at ambient field conditions and employs either a simple filtration prep or a
gravity-driven filtration prep for sample preparation. This system shows a turnaround time
from sample preparation to reading results in less than an hour. The LAMP assay is performed
and results analysed in a bespoke incubator/reader which allows testing of 10 samples per run
thereby restricting the throughput of this assay [24].
Our study reports the development and performance evaluation of a novel high throughput
(HTP) 96-well sample processing system for LAMP detection of malaria parasites, with turn-
around from DNA extraction of 96 samples (94 samples and 2 controls) to reading results tak-
ing less than 2 hours. This system allows parallel processing of a large number of samples
using a set of three inter-locking 96-well plates, with vacuum pressure transfer between plates,
reducing the need for pipetting and eliminating centrifugation requirements. HTP-LAMP per-
formance is evaluated using both dried blood spots on filter paper as well as liquid whole
blood, where the samples are of known infection status as pre-determined by gold standard
nested PCR (nPCR) performed prior to this study.
Materials and methods
Ethics
This study was awarded ethical clearance by the Research Ethics Committee of University Col-
lege London Hospitals (REC reference 07/Q0505/60). The samples were collected as part of
routine diagnostics and stored as fully anonymised samples surplus to diagnostic require-
ments. Therefore patient consent was not required.
Samples and study site
The performance of the HTP-LAMP assay was characterized using a bank of 705 venous blood
samples anticoagulated with either ethylenediaminetetraacetic acid (EDTA) or heparin, origi-
nally taken for routine diagnosis of malaria from patients of the Hospital for Tropical Diseases
(HTD) London, from January to July 2011. Samples from sequential patients with a history of
previous malarial infection or presenting with symptoms indicative of current malaria infec-
tion were tested within the Department of Clinical Parasitology at HTD for blood parasites
using routine microscopy. The samples were anonymised and subsequently analysed by boil
and spin LAMP (BS-LAMP) and PCR [18]. Excess anonymised samples from this study were
stored at -20˚C until their use for the evaluation of the high throughput sample processing sys-
tem for LAMP.
The HTP-LAMP assays were performed by a single study researcher in the Department of
Clinical Parasitology at HTD. The researcher did not have access to the database and was
blinded to microscopy, PCR and BS-LAMP results.
Clinical evaluation of high throughput LAMP
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HTP sample processing
The HTP system was developed in association with 42 Technology Ltd., a commercial medical
device development company, and Porvair Sciences, a company specialized in filtration plates,
to convert the low throughput PURE extraction system into one that could process up to 96
samples within an hour. The extraction consumables kit includes a chart for recording the
location of samples within the plate, three disposable 96 well plates for lysis, purification and
elution and all reagents required (Fig 1). The hardware for this system consists of a heating
block with bespoke machined insert for the blood lysis step, a shaker, a vacuum pump (with
bespoke timer) and manifold to facilitate transfer of samples between plates (Fig 2). The system
is “keyed” to prevent plates being inappropriately rotated in the system and ensure the prove-
nance of each DNA extract. Each kit has a set of unique stickers to be affixed to each of the
plates and the sample sheet to ensure there is no mix up where multiple batches of plates are to
be processed. The whole system is designed to fit within a mobile flight case for transport (Figs
3 and 4) and to be run in laboratories/field stations with a steady power supply, but no other
specialist equipment. LAMP amplification kits were purchased from Eiken Chemical Com-
pany (Japan).
Samples were tested as both whole blood (WB) and dried blood spots (DBS). The high
throughput sample processing system was carried out in parallel batches of 96 samples consist-
ing of 47 DBS samples, 47 WB samples, and Plasmodium positive and negative extraction
controls.
The DBS samples were prepared by pipetting 20 μL of blood onto specifically designed
shaped filter paper devices [25], which were then shut and placed in a zip-lock bag for 1 hour
prior to DNA extraction to simulate sample collection and transport. The LYSIS plate was pre-
pared by pipetting 498 μL of lysis fluid into each well using a multi-channel pipette. The filter
paper sticks were cut a few millimetres above the unsoaked part directly into appropriate wells
of the LYSIS plate, ensuring the scissors did not touch blood. For WB samples, 20 μL of WB
Fig 1. Layout of the contents of the high throughput sample processing kit on the bench. The contents
of the sample processing kit which includes a LYSIS plate, PURE plate, EXTRACT plate, sample record
sheet, lysis fluid, individual foam plugs and instruction manual.
doi:10.1371/journal.pone.0171126.g001
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was pipetted into appropriate wells of the LYSIS plate. Foam plugs were pushed down into
each well and the LYSIS plate was placed in a shaker for 10 min at 750 revolutions per minute
(rpm) to facilitate liberation of the blood and DNA from the filter papers. The LYSIS plate was
placed in a hot block at 95˚C for 14 min, then immediately removed, and placed on top of the
vacuum manifold containing the PURE plate. Lysed samples were then transferred under vac-
uum pressure to the PURE plate. The PURE plate was placed in a shaker at 1000 rpm for 10
min, then placed on top of the vacuum manifold containing the EXTRACT plate. Purified
DNA was transferred under vacuum pressure to the EXTRACT plate. Eluted DNA was used
immediately in the LAMP reactions.
A multi-channel pipette was used to transfer 30 μL of DNA into Pan-LAMP (all species of
Plasmodium) detection tubes. Tubes were inverted, incubated to allow dissolving of dried
LAMP reagents in the tube caps, mixed by inversion, contents collected at the bottom of tubes,
and incubation for amplification was performed immediately.
Fig 2. Layout of the high throughput set-up on the bench. The layout of the high throughput set-up which includes a shaker, hot block, vacuum manifold
and pressure gauge.
doi:10.1371/journal.pone.0171126.g002
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An instructional video demonstrating the standard operating procedure for the high
throughput LAMP sample processing kit and LAMP amplification is available at https://youtu.
be/95g0nMbaOGg
Fig 3. The contents of high throughput LAMP set-up packed into a transportable hard-cover case.
doi:10.1371/journal.pone.0171126.g003
Fig 4. The transportable hard-cover case containing the high throughput LAMP set-up.
doi:10.1371/journal.pone.0171126.g004
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LAMP amplification
Reaction tubes were incubated at 65˚C for 40 min in a real time LA-320C turbidimeter (Eiken
Chemical). Reactions were terminated by incubating at 80˚C for 5 min. LAMP was performed
in batches of 32 samples which included positive and negative control samples. The real time
turbidity data were recorded, positives scored based on the first point at which the change in
turbidity increased by 0.1 optical density (OD) units per second.
BS-LAMP vs. HTP-LAMP
A comparison between the HTP-LAMP and BS-LAMP sample processing was performed
using a tenfold dilution series of P. falciparum infected blood ranging from 10,000 parasites/μL
to 0.1 p/μL (calibrated against the Plasmodium falciparum WHO International Standard) [26].
DNA was extracted via both boil and spin method ([20], S1 Text), and high throughput PURE
method, and LAMP amplified in malaria pan detection tubes.
Statistical analysis
A pairwise comparison for non-equivalence between reference (nPCR) and index test
(WB-HTP-LAMP or DBS-HTP-LAMP) was determined by the McNemar test. The null
hypothesis assuming no difference in performance between the reference test and index test
was retained for P values 0.05. Statistical analysis was conducted using STATA 12.1 (Stata
Corp, Texas, USA).
The study was performed in compliance with the updated version of Standards for Report-
ing of Diagnostic Accuracy (STARD) [27].
Stability of PURE extracts
Stability of PURE extracts was tested using infected blood, PURE buffer and powder in the vol-
umes used for the original PURE system. 35 μL of blood containing 0.2, 0.8, 2.0 or no parasites
(neg) per microLitre was used in each extraction to produce over 180 μL of eluate in a 1.5 mL
snap lock tube. The eluate was then aliquoted into 200 μL individual tubes and used immedi-
ately (0 hours) or after pre-defined incubations. Tubes were incubated at 24, 37 or 45 degrees
C for various durations before use. The eluates were then added to Pan reaction tubes and run
on a turbidimeter (S2 Fig).
Results
High throughput sample processing system development
The system was developed to allow the PURE technology to be re-engineered into a 96 well
format. 96 well filter plates were tested to evaluate the optimum filter composition for fluid
retention, DNA penetration and burst pressure. A bespoke manifold system was developed to
allow keying of plates and easy operation of the system, whilst the optimum pump speed and
pressure was also evaluated with a number of commercial systems. A hot air heating system
for the LYSIS plate was replaced with a bespoke tooled aluminium heating block, which was
tested by thermal mapping to ensure correct heating characteristics. The optimum PURE to
lysis fluid ratios were evaluated to ensure cross contamination was minimised while maximis-
ing repeatability and sensitivity. Cross contamination was also minimised by the use of the
drip control layer on the elution plate, a foam barrier on the bottom of the LYSIS plate, and
packing prevention inserts in the PURE plate. The drip catcher was a bespoke moulded rubber
system to ensure no leakage of hot, caustic lysis fluid. Numerous foam samples were evaluated
to find one that would prevent leakage of lysis fluid in the event of a plate being dropped,
Clinical evaluation of high throughput LAMP
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whilst allowing thermal expansion in the gas layer to pass through so as not to increase the
intra-well pressure during heating.
High throughput sample processing system evaluation
Comparison of the BS-LAMP versus the HTP-LAMP extraction was carried out using a range
of dilutions of known Plasmodium positive blood samples. Figs 5 and 6 show the increase in
turbidity with time measured for 10,000 p/μL to 0.1 p/μL for BS-LAMP and HTP-LAMP
respectively. All samples from 10,000 p/μL to 1 p/μL amplified with both methods. The 1 p/μL
sample reached turbidity at ~25 min for BS-LAMP and ~23 min for HTP-LAMP. The 0.1 p/μL
sample did not amplify with either method, indicating a limit of detection of 1 p/μL. This was
seen with all three repeats of the experiment.
HTP-LAMP vs. PCR
From the 705 samples previously tested by PCR, microscopy and BS-LAMP for Plasmodium
infection, 699 EDTA blood samples were available for use in the high throughput sample pro-
cessing system evaluation, where DNA was extracted from both dried blood spots and whole
blood. Six samples were excluded from this study due to insufficient material for testing in the
original archived EDTA sample (Fig 7).
When clinical sensitivity and specificity was calculated for the HTP LAMP a similar diag-
nostic sensitivity and specificity to the reference 3-well nPCR was seen using both dried blood
spots (DBS-HTP-LAMP) and whole blood (WB-HTP-LAMP) as the initial sample (Table 1).
Fig 5. Limit of detection of LAMP reactions using the boil and spin DNA extraction method. Representative
amplifications experiments using serial dilutions of samples of known parasitaemia (quantified using the WHO
International Standard as calibrator).Quantification was achieved by extracting DNA from a parasite dilution series
made in whole blood using a Qiacube and DNA blood mini kit (Qiagen, De Hilden). Extracted DNA was then quantified
using the Shokoples real time PCR [28] against a within run standard curve created from DNA extracted from the WHO
international standard using the same methodology. Parasite count per microLitre was calculated given an initial
parasite burden of 10% in the WHO standard and an assumed red cell count of 5 x106 red cells per microLitre. Mean
time to turbidity in minutes as follows: 10,000 p/μL = 15.8; 1,000 p/μL = 15.9; 100 p/μL = 16.7; 10 p/μL = 18.2; 1 p/
μL = 24.5.
doi:10.1371/journal.pone.0171126.g005
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The WB-HTP-LAMP assay failed to detect 1 of 69 positive PCR samples, resulting in a sen-
sitivity of 98.6% (95% CI, 95.7–100) for this assay (Table 1). This single false negative sample
contained <1 p/μL according to the real time PCR analysis. HTP-LAMP therefore has a
clinical sensitivity of 100% in samples with1 p/μL when compared to 3-well nPCR. Two
WB-HTP-LAMP positive samples were negative by nPCR, giving a specificity of 99.7% (95%
CI, 99.2–100) (Table 1). Both samples showed late amplification, past 30 min. The positive pre-
dictive value (PPV) and negative predictive value (NPV) of WB-HTP-LAMP was 97.1% and
99.8% respectively, when compared with nPCR (Table 1). Superior results were seen when all
samples <1 p/μL were excluded. A pairwise comparison between reference nPCR and the
index text WB-HTP-LAMP showed statistical equivalence between both tests (P = 0.5637)
(Table 1).
The DBS-HTP-LAMP assay failed to detect 2 of 69 positive PCR samples, resulting in a sen-
sitivity of 97.1% (95% CI, 93.1–100) for this assay (Table 1). The two false negative samples
contained <1 p/μL according to real time PCR analysis [18]. HTP-LAMP therefore has a
clinical sensitivity of 100% in samples with1 p/μL when compared to 3-well nPCR. The
DBS-HTP-LAMP assay was 100% specific against nPCR (Table 1). Compared with nPCR, the
PPV and NPV were 100% and 99.7% respectively for DBS-HTP-LAMP (Table 1). These results
were seen when all samples were included in the analysis. Superior results were seen when all
samples <1 p/μL were excluded. The DBS-LAMP index test was found to be statistically non-
inferior to the reference nPCR test (P = 0.157) as calculated by the McNemar test (Table 1).
Analysis of the results following stratification of parasitaemia with a cut-off at 2 p/μL
(WHO recommendation for performance of NAATs [29], shows a high level of diagnostic
accuracy of the WB HTP-LAMP assay, similar to nPCR at2 p/μL, with 100% sensitivity and
Fig 6. Limit of detection of LAMP reactions using the high throughput sample processing system. Representative
amplifications experiments using serial dilutions of samples of known parasitaemia (quantified using the WHO International
Standard as calibrator). Mean time to turbidity in minutes as follows: 10,000 p/μL = 17.5; 1,000 p/μL = 18.5; 100 p/μL = 19.4; 10 p/
μL = 21.3; 1 p/μL = 22.9.
doi:10.1371/journal.pone.0171126.g006
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specificity (Table 2). At< 2 p/μL, WB-HTP-LAMP showed diagnostic accuracy similar to
nPCR with a sensitivity of 88.9% (95% CI, 77.1–100) and specificity of 99.7% (95% CI, 99.2–
100) (Table 2).
A stratified analysis of the DBS-HTP-LAMP assay shows a high level of diagnostic accuracy
similar to nPCR at 2p/μL with 100% sensitivity and 100% specificity. The parasite densities
in this group ranged from 2–912896 p/μL [18], with a geometric mean of 711.5 p/μL (Table 2).
At < 2 p/μL, DBS-HTP-LAMP showed a lower diagnostic accuracy compared to nPCR
with a sensitivity of 77.8% (95% CI, 54.3–99.5) and 100% specificity (Table 2). The parasite
Fig 7. Flow chart of the study. The results of the two index tests, DBS-HTP-LAMP and WB-HTP-LAMP, against the gold standard nPCR results are
summarized. Discrepancies between the gold standard and the index tests are highlighted. Abbreviation: EDTA ethylenediaminetetraacetic acid; PCR
polymerase chain reaction; HTP-LAMP dried blood spot high throughput loop mediated isothermal amplification; DBS dried blood spot; WB whole blood.
doi:10.1371/journal.pone.0171126.g007
Table 1. Comparison of Malaria HTP-LAMP results from 699 DBS and WB samples against the equivalent gold standard nPCR results from 2011.
Comparison PCR(+) PCR (-) Sensitivity (95% CI) Specificity (95% CI) PPV, % NPV, %
DBS-HTP-LAMP vs. nPCRn = 699
DBS HTP-LAMP (+) 67 0 97.1 100 100 99.7
DBS HTP-LAMP (-) 2 630 (93.1–100)
WB-HTP-LAMP vs. nPCR n = 699
WB-HTP-LAMP (+) 68 2 98.6 99.7 97.1 99.8
WB-HTP-LAMP (-) 1 628 (95.7–100) (99.2–100)
The McNemar test, used to conduct a pairwise comparison between reference nested PCR and index text WB-HTP-LAMP, showed statistical equivalence
between both tests (P = 0.5637), while the DBS-LAMP index test was found statistically non-inferior to the reference nPCR test (P = 0.157).
doi:10.1371/journal.pone.0171126.t001
Clinical evaluation of high throughput LAMP
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densities in this group ranged from 1.5 p/μL to undetected via qPCR [18], with a geometric
mean of 1.03 p/μL (Table 2).
Discussion
Active identification and treatment of sub-patent infections in asymptomatic parasite carriers
is crucial to achieving the World Health Organization (WHO) goal of 90% reduction in global
malaria incidence and mortality rates by 2030 [30].
Early malaria elimination interventions in the 1950s-1970s involved mass drug administra-
tion (MDA) programmes where entire populations were administered therapeutic antimalarial
drugs regardless of infection status, parasitaemia or symptoms with the aim of interrupting
transmission. Whilst this strategy provided a means of treating asymptomatic carriers thereby
reducing transmission rates, widespread issues regarding efficacy, resources, sustainability and
increased drug resistance meant this approach was not feasible as a long term solution, though
development of new antimalarial drugs may resolve some of these concerns [31].
As more countries move towards elimination, the importance of sub-microscopic reservoirs
increases, thereby sustaining transmission from humans to mosquitoes. Recent studies have
Table 2. Stratified analysis of parasitaemia comparing DBS and WB HTP-LAMP against nPCR with a cut-off at 2 p/μL.
Parasitaemia >2 p/μL PCR
(+)
PCR
(-)
Sensitivity
(95% CI)
Specificity
(95% CI)
PPV,
%
NPV,
%
Parasites/μLa
(Geometric
mean)
Plasmodium species distribution
DBS-HTP-LAMP vs.
nPCR n = 688
DBS HTP-LAMP (+) 60 0 100 100 100 100 2.0–912896.0 n = 57, P. falciparum from 4 p/μL
DBS HTP-LAMP (-) 0 628 (711.5) n = 2, P. vivax each at 2 p/μL;n = 1, P. ovale at
2 p/μL
WB-HTP-LAMP vs.
nPCR n = 688
WB-HTP-LAMP (+) 60 0 100 100 100 100 2.0–912896.0 n = 57, P. falciparum from 4 p/μL
WB-HTP-LAMP (-) 0 628 (711.5) n = 2, P. vivax each at 2 p/μL;n = 1, P. ovale at
2 p/μL
Parasitaemia < 2p/μL PCR
(+)
PCR
(-)
Sensitivity
(95% CI)
Specificity
(95% CI)
PPV,
%
NPV,
%
Parasites/μLa
(Geometric
mean)
Plasmodium species distribution
DBS-HTP-LAMP vs.
nPCR n = 639
DBS HTP-LAMP (+) 7 0 77.8 100 100 99.7 undetected-1.5 n = 5, P. falciparum from 0.5–1.5 p/μL
DBS HTP-LAMP (-) 2 630 (54.3–100) (1.03) n = 2, P. falciparum, P. ovale (undetected by
qPCRb, DBS positive) n = 1, P. falciparum at
0.8 p/μL,
(DBS negative)
n = 1, P. falciparum (undetected by qPCRb;
DBS negative)
WB-HTP-LAMP vs.
nPCR n = 639
WB-HTP-LAMP (+) 8 2 88.9 99.7 80 99.8 undetected-1.5 n = 5, P. falciparum from 0.5–1.5 p/μL
WB-HTP-LAMP (-) 1 628 (71.1–100) (99.2–100) (1.03) n = 2, P. falciparum (undetected by qPCRb,
WB positive) n = 1, P. ovale (undetected by
qPCRb, WB positive)n = 1, P. falciparum at
0.8 p/μL, (WB negative)
a Range of parasite densities for PCR positive results
b Parasite density could not be quantified due to negative qPCR results.
doi:10.1371/journal.pone.0171126.t002
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shown sub-microscopic infections are the source of 20–50% of human to mosquito infections in
areas with low to very low transmission intensity, and are contributors to sustained transmission
in these areas [6]. Detection of these reservoirs becomes increasingly important as control efforts
move towards reduced transmission rates, and is key to interrupting transmission.
MSAT is aimed at screening large numbers of people to detect and treat anyone infected
with malaria parasites. Furthermore, this allows the detection of carriers with low-density
asymptomatic cases to also be identified and treated, thereby reducing transmission rates by
targeting the human reservoir and interrupting transmission [32]. However, limitations of this
strategy involve diagnostic accuracy and sensitivity of the screening method, where accurate
and efficient detection requires a highly sensitive, field applicable molecular screening tool,
with the capacity to diagnose large numbers of cases. The HTP-LAMP platform described in
this paper offers the potential to be used as one such screening tool, and shows significant
improvements and advantages over previously described versions of LAMP.
The HTP system accommodates complete processing and evaluation of up to 94 samples
with controls in less than two hours. With two people performing this assay, double the num-
ber of samples can be tested, making it possible to scan 400 to 500 samples a day. Therefore,
this system allows significantly faster turnaround time for processing large batches of samples
compared to other diagnostic methods, including other high throughput LAMP kits ([21–24],
Table C in S1 Text). In addition, DNA extracted using this system remains stable on the bench
at room temperature for one day, facilitating repeat testing of positives from the same plate for
species identification (S2 Fig).
With high throughput studies, the risk of incorrect sample loading or sample mix up is
high. This system includes sample processing sheets, ID stickered plates specific to each kit to
ensure correct loading of samples and easily identifiable plates which eliminates the risk of
mixing up specimens or plates. The inter-locking plates are also designed to fit in one specific
orientation which also minimises incorrect handling.
Use of dried blood spot filter paper devices has provided an efficient means of collecting
and transporting large numbers of patient blood samples of defined volume ready for testing
by molecular and serological methods. Prior studies have shown DNA extracted from these
devices for malaria LAMP detection perform similar to DNA extracted from whole blood [33].
DNA extracted from DBS using a DNA blood mini kit (Qiagen Germany) has shown a detec-
tion limit of 1–2 p/μL [25] and the PURE DNA extraction method giving an LOD of 1.5 p/μL
for DBS samples compared to 0.5 p/μL LOD of whole blood [11, 18]. Our results show that
this relatively simple high throughput system for DNA extraction works as well using both
DBS and WB samples with comparable sensitivity, detecting low density parasitaemias down
to 1 p/μL, similar to the diagnostic accuracy of the gold standard PCR [1]. Given that previous
studies have only been reported on Whatmann 3MM paper to date, it is unknown how papers
other than 3MM or GB003 may perform with this system.
Utilisation of DBS specimens, for which only a pair of scissors is required for loading sam-
ples directly into the DNA extraction stage, provides an efficient means of processing large
batches of samples and would be ideal for use in field environments. This system would be
well suited for testing for infection using either source, a criterion particularly relevant during
mass screening and field testing procedures and would be valuable in non-referral laboratory
settings. The components of the HTP-LAMP kit fit on a small work bench and pack into an
easily transportable case ready for deployment (Figs 3 and 4), thus making this system ideal for
high throughput detection in remote field diagnostic labs, mobile screening stations and mass
screening and treatment programmes.
Limitations of the current study involved a longer time to read results for all 96 samples due
to the limited capacity of the 32 well turbidimeter. However, commercially available 96-well
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turbidimeters could be used to increase the throughput, allowing faster detection and quicker
turnaround time from sample processing to reading results. Throughput could also be in-
creased by the use of simple hot blocks with fluorescent calcein used for visual confirmation of
positive results under a simple UV lamp. Other limitations of this study include the require-
ment of a stable power supply as well as maintenance of sterile conditions and the cost associ-
ated with the HTP set-up and LAMP reaction tubes.
Field trials using the HTP-LAMP system to test asymptomatic individuals have been per-
formed in Zanzibar [34]. Further work will be needed fully to evaluate diagnostic sensitivity in
field settings, particularly in areas with different malaria prevalence rates. The implementation
of this robust and highly sensitive diagnostic system in endemic countries, particularly where
resources are scarce and laboratory infrastructure lacking, would facilitate a more accurate
means of detection of low-density parasite infections, particularly crucial for countries close to
elimination. Such strategies would enable rapid treatment and proper surveillance required for
successful elimination of malaria.
Supporting information
S1 Fig.
(TIF)
S2 Fig.
(TIF)
S1 Text.
(DOCX)
Acknowledgments
The authors are grateful to Eiken Chemical Co. Ltd (Japan) for providing the PURE powder
and for counselling during the high-throughput sample processing kit development. We
would also like to thank Julie Watson from the Department of Clinical Parasitology, Hospital
for Tropical Diseases for assistance with general laboratory administration. This manuscript is
part of a collaboration to develop improved malaria diagnostic tests between the Hospital for
Tropical Diseases and the Foundation for Innovative New Diagnostics, Geneva, Switzerland.
Author contributions
Conceptualization: XCD IJG SDP DB.
Formal analysis: RSP SDP.
Funding acquisition: IJG.
Investigation: RSP.
Methodology: XDC SDP FT JO NB.
Project administration: IJG PLC.
Resources: FT JO NB.
Supervision: SDP XCD PLC.
Validation: SDP PLC.
Visualization: RSP.
Clinical evaluation of high throughput LAMP
PLOS ONE | DOI:10.1371/journal.pone.0171126 February 6, 2017 13 / 15
Writing – original draft: RSP.
Writing – review & editing: RSP SDP XCD.
References
1. WHO. New perspectives: Malaria diagnosis. Report of joint WHO/USAID informal consultation 25–27
October 1999. Geneva: World Health Organization; 1999.
2. Mouatcho JC, Goldring JPD. Malaria rapid diagnostic tests: challenges and prospects. J Med Microbiol.
2013; 62:1491–505. doi: 10.1099/jmm.0.052506-0 PMID: 24048274
3. Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G. Rapid diagnostic tests for
malaria at sites of varying transmission intensity in Uganda. J Infect Dis. 2008; 197:510–8. doi: 10.1086/
526502 PMID: 18240951
4. Rakotonirina H, Barnadas C, Raherijafy R, Andrianantenaina H, Ratsimbasoa A, Randrianasolo L, et al.
Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in
malaria-endemic countries. Am J Trop Med Hyg. 2008; 78(2):217–21. PMID: 18256418
5. WHO. World Malaria Report 2015. Geneva, Switzerland: World Health Organization; 2015.
6. Okell LC, Bousema T, Griffin JT, Ouedragogo AL, Ghani AC, Drakely CJ. Factors determining the
occurence of submicroscopic malaria infections and their relevance for control. Nature Communications
2012; 3(1237).
7. WHO. Guidelines for the treatment of malaria. Vol. 2nd ed.: Geneva: World Health Organization,
2010.
8. Polley SD, Sutherland CJ, Regan F, Hassan M, Chiodini PL. Increased sensitivity for detecting malaria
parasites in human umbilical cord blood using scaled-up DNA preparation. Malaria J. 2012; 11(62).
9. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of four human malaria para-
site species in field samples by the polymerase chain reaction and detection of a high prevalence of
mixed infections. Mol Biochem Parasitol. 1993; 58:283–92. PMID: 8479452
10. Cook J, Aydin-Schmidt B, Gonzalez IJ, Bell D, Edlund E, Nassor MH, et al. Loop-mediated isothermal
amplification (LAMP) for point-of-care detection of asymptomatic low-density malaria parasite carriers
in Zanzibar. Malaria J. 2015; 14(43).
11. Hopkins H, Gonzalez IJ, Polley SD, Angutoko P, Ategeka J, Asiimwe C, et al. Highly sensitive detection
of malaria parasitemia in a malaria-endemic setting: Performance of a new loop-mediated isothermal
amplification kit in a remote clinic in Uganda. J Infect Dis. 2013; 208:645–52. doi: 10.1093/infdis/jit184
PMID: 23633405
12. Han ET. Loop-mediated isothermal amplification test for the molecular diagnosis of malaria. Expert
Reviews in Molecular Diagnosis. 2013; 13:205–18.
13. Poon LL, Wong BW, Ma EH, Chan KH, Chow LM, Abeywickreme W, et al. Sensitive and inexpensive
molecular test for falciparum malaria: detection Plasmodium falciparum DNA directly from heat-treated
blood by loop-mediated isothermal amplification. Clin Chem. 2006; 52:303–96. doi: 10.1373/clinchem.
2005.057901 PMID: 16339303
14. Njiru ZK. Loop-mediated isothermal amplification technology:towards point of care diagnostics. PLoS
Negl Trop Dis. 2012; 6:e1572. doi: 10.1371/journal.pntd.0001572 PMID: 22745836
15. Aydin-Schmidt B, Xu W, Gonzalez IJ, Polley SD, Bell D, Shakely D. Loop-mediated isothermal amplifi-
cation (LAMP) accurately detects malaria DNA from filter paper blood samples of low density parasitae-
mias. PLoS One. 2014; 9:e103905. doi: 10.1371/journal.pone.0103905 PMID: 25105591
16. Morris U, Khamis M, Aydin-Schmidt B, Abass AK, Msellem MI, Nassor MH, et al. Field deployment of
loop-mediated isothermal amplification for centralized mass-screening of asymptomatic malaria in Zan-
zibar: a pre-elimination setting. Malaria J. 2015; 14(205).
17. Polley SD, Mori Y, Watson J, Perkins MD, Gonzalez IJ, Notomi T, et al. Mitochondrial DNA targets
increase sensitivity of malaria detection using loop-mediated isothermal amplification. J Clin Microbiol.
2010; 48(8):2866–71. doi: 10.1128/JCM.00355-10 PMID: 20554824
18. Polley SD, Gonzalez IJ, Mohamed D, Daly R, Bowers K, Watson J, et al. Clinical evaluation of a loop-
mediated amplification kit for diagnosis of imported malaria. J Infect Dis. 2013; 208(637–644).
19. Vallejo AF, Martinez NL, Gonzalez IJ, Arevalo-Herrera M, Herrera S. Evaluation of the loop mediated
isothernal DNA amplification (LAMP) kit for malaria diagnosis in P. vivax endemic settings of Colombia.
PLOS Negl Trop Dis. 2015; 9(1):e3453. doi: 10.1371/journal.pntd.0003453 PMID: 25569550
Clinical evaluation of high throughput LAMP
PLOS ONE | DOI:10.1371/journal.pone.0171126 February 6, 2017 14 / 15
20. FIND. Manual of Standard Operating Procedures for Malaria LAMP.: Foundation for Innovative New
Diagnostics; Available from: http://www.finddiagnostics.org/programs/malaria-afs/lamp/standard_
procedures/index.html.
21. Britton S, Cheng Q, Sutherland CJ, McCarthy JS. A simple, high-throughput, colourimetric, field applica-
ble loop-mediated isothermal amplification (HtLamp) assay for malaria elimination. Malaria J. 2015; 14
(335).
22. Britton S, Cheng Q, Grigg MJ, Poole CB, Pasay C, William T, et al. Sensitive detection of Plasmodium
vivax using a high-throughput, colourimetric loop mediated istothermal amplification (HtLAMP) platform:
a potential novel tool for malaria elimination. PLoS Negl Trop Dis. 2016; 10(2).
23. Lucchi NW, Ljolje D, Silva-Flannery L, Udhayakumar V. Use of malachite green-loop mediated isother-
mal amplification for detection of Plasmodium spp. parasites. PLoS One. 2016; 11(3).
24. Lucchi NW, Gaye M, Diallo MA, et al. Evaluation of the Illumigene Malaria LAMP: A Robust Molecular
Diagnostic Tool for Malaria Parasites. Scientific Reports. 2016; 6(36808).
25. Polley SD, Bell D, Oliver J, Tully F, Perkins MD, Chiodini PL, et al. The design and evaluation of a
shaped filter collection device to sample and store defined volume dried blood spots from finger pricks.
Malaria J. 2015; 14(45).
26. Padley DJ, Heath AB, Sutherland C, Chiodini PL, Baylis SA. Establishment of the 1st World Health
Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification tech-
nique (NAT)-based assays. Malaria J. 2008; 7(139).
27. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. STARD 2015: an updated list of
essential items for reporting diagnostic accuracy studies. BMJ. 2015; 351 (h5527).
28. Shokoples SE, Ndao M, Kowalewska-Grochowska K, Yanow SK. Multiplexed Real-Time PCR Assay
for Discrimination of Plasmodium Species with Improved Sensitivity for Mixed Infections. J Clin. Micro-
biol. 2009; 46 (4).
29. WHO. Evidence review group on malaria diagnosis in low transmission settings 16–18 December 2013.
Geneva: World Health Organization; 2014.
30. WHO. Global technical strategy for malaria 2016–2030. Geneva: World Health Organization; 2015.
31. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for
malaria. Cochrane Database of Systematic Reviews. 2013; 12.
32. Okell LC, Griffin JT, Kleinschmidt I, Hollingsworth TD, Churcher TS, White MJ, et al. The potential con-
tribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One. 2011; 6(5):
e20179. doi: 10.1371/journal.pone.0020179 PMID: 21629651
33. Modak SS, Barber CA, Geva E, Abrams WR, Malamud D, Ongagna YSY. Rapid point-of-care isother-
mal amplification assay for the detection of malaria without nucleic acid purification. Infectious Dis-
eases: Research and Treatment. 2016; 9.
34. Aydin-Schmidt B, Morris U, Ding XC, Jovel I, Msellem MI, Bergman D, et al. Field evaluation of a High
Throughput Loop Mediated Isothermal Amplification for the detection of asymptomatic Plasmodium
infections in Zanzibar. PLoS One. 2017; 12(1):e0169037. doi: 10.1371/journal.pone.0169037 PMID:
28095434
Clinical evaluation of high throughput LAMP
PLOS ONE | DOI:10.1371/journal.pone.0171126 February 6, 2017 15 / 15
